These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28625003)

  • 21. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new application of value-stream mapping in new drug development: a case study within Novartis.
    Heinzen M; Mettler S; Coradi A; Boutellier R
    Drug Discov Today; 2015 Mar; 20(3):301-5. PubMed ID: 25448754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lost opportunities.
    Phan P; Wong D
    Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
    [No Abstract]   [Full Text] [Related]  

  • 25. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 27. Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.
    Shi YZ; Hu H; Wang C
    Global Health; 2014 Nov; 10():78. PubMed ID: 25406839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mergers and innovation in the pharmaceutical industry.
    Comanor WS; Scherer FM
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melding regulatory, pharmaceutical industry, and U.S. payer perspectives on improving approaches to heterogeneity of treatment effect in research and practice.
    Willke RJ; Crown W; Del Aguila M; Cziraky MJ; Khan ZM; Migliori R
    Value Health; 2013; 16(6 Suppl):S10-5. PubMed ID: 24034306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing customer databases.
    Rao SK; Shenbaga S
    Mark Health Serv; 2000; 20(4):10-4. PubMed ID: 11209474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outsourcing chemical synthesis in the drug discovery process.
    Festel G
    Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Focused Drug Development: A New Direction for Collaboration.
    Perfetto EM; Burke L; Oehrlein EM; Epstein RS
    Med Care; 2015 Jan; 53(1):9-17. PubMed ID: 25494232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future pharmaceutical research: the need to look beyond science.
    Seeger S
    Future Med Chem; 2014 May; 6(7):721-3. PubMed ID: 24941866
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.
    Gromo G; Mann J; Fitzgerald JD
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-centered innovation in health care organizations: a conceptual framework and case study application.
    Hernandez SE; Conrad DA; Marcus-Smith MS; Reed P; Watts C
    Health Care Manage Rev; 2013; 38(2):166-75. PubMed ID: 22669050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silo busting: how to execute on the promise of customer focus.
    Gulati R
    Harv Bus Rev; 2007 May; 85(5):98-108, 145. PubMed ID: 17494254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro factors bringing the pharmaceutical industry to a seismic shaking a qualitative research.
    Dierks RML; Bruyère O; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):267-274. PubMed ID: 28679327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.